Early diagnosis of multiple endocrine neoplasia type 2B: a challenge for physicians

A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families.

Familial GH-secreting tumors are seen in association with three separate hereditary clinical syndromes: (1) multiple endocrine neoplasia type 1 (MEN1), (2) Carney complex (CNC), and

The prevalence of pituitary tumors in multiple endocrine neoplasia type 1 may vary from 10% to 60% depending on the studied series, and such tumors may occur as the first

Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D’etude des Tumeurs

Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung’s disease

Finally, pre-surgical clinical and genetic diagnosis of multiple endocrine neoplasia type 1 syndrome and localization of multiple endocrine neoplasia type 1- related tumors are

Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum

Carney complex (CNC) is a familial mul- tiple neoplasia characterized by cardiac and cutaneous myxomas, multiple endocrine tumors (in the pituitary, thyroid, ovaries and testicles),